ストックスクリーナーアプリを入手
1.50
2.74%
0.04
アフターアワーズ：
1.51
0.01
+0.67%
前日終値:
$1.46
開ける：
$1.42
24時間の取引高:
43,461
Relative Volume:
0.16
時価総額：
$17.36M
収益：
$996.00K
当期純損益:
$-6.09M
株価収益率:
-2.8302
EPS:
-0.53
ネットキャッシュフロー:
$-9.76M
1週間 パフォーマンス:
+2.74%
1か月 パフォーマンス:
+51.52%
6か月 パフォーマンス:
+7.14%
1年 パフォーマンス:
-29.25%
1日の値動き範囲:
$1.42
$1.52
1週間の範囲:
$1.40
$1.54
52週間の値動き範囲:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
名前
Therapeuticsmd Inc
セクター
電話
561-961-1900
住所
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.50 | 16.90M | 996.00K | -6.09M | -9.76M | -0.53 |
|
HLN
Haleon Plc Adr
|
10.80 | 48.39B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
163.04 | 70.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.85 | 3.54M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.11 | 45.20B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.94 | 19.42B | 16.54B | -1.64B | 749.00M | -1.45 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-07 | ダウングレード | Jefferies | Hold → Underperform |
| 2020-05-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 開始されました | Guggenheim | Buy |
| 2019-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-30 | 再開されました | Noble Capital Markets | Outperform |
| 2018-06-15 | 開始されました | JP Morgan | Overweight |
| 2017-09-08 | 開始されました | Morgan Stanley | Equal-Weight |
| 2017-07-11 | アップグレード | Oppenheimer | Perform → Outperform |
| 2017-05-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 再開されました | Jefferies | Buy |
| 2016-11-22 | 開始されました | Oppenheimer | Outperform |
| 2016-11-07 | 再開されました | Guggenheim | Buy |
| 2016-04-04 | 開始されました | Goldman | Buy |
| 2015-12-08 | 繰り返されました | Jefferies | Buy |
| 2015-12-08 | 繰り返されました | Stifel | Buy |
| 2015-09-21 | 繰り返されました | Jefferies | Buy |
| 2015-06-09 | 開始されました | Guggenheim | Buy |
| 2014-07-08 | 開始されました | FBR Capital | Outperform |
| 2014-04-17 | 繰り返されました | Noble Financial | Buy |
| 2014-01-28 | 繰り返されました | Noble Financial | Buy |
すべてを表示
Therapeuticsmd Inc (TXMD) 最新ニュース
TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com - Defense World
TherapeuticsMD Reports Improved Q1 2025 Results - TipRanks
TherapeuticsMD Announces First Quarter 2025 Financial Results | - GuruFocus
TherapeuticsMD: Q1 Earnings Snapshot - CT Insider
TherapeuticsMD Announces First Quarter 2025 Financial Results - BioSpace
TherapeuticsMD Inc Reports Q1 2025 Results: EPS at -$0.06, Reven - GuruFocus
TherapeuticsMD Reports Q1 2025 Financial Results - TipRanks
TherapeuticsMD Q1 Operating Expenses USD 1.264 Million - marketscreener.com
TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com - Defense World
Today's Dead Cat Bounce Stock: TherapeuticsMD (TXMD) - TheStreet
StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Press Release Distribution & PR Platform - ACCESS Newswire
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD CEO Marlan Walker acquires $489 in common stock By Investing.com - Investing.com Canada
TherapeuticsMD director Tommy Thompson acquires $325 in stock - Investing.com Australia
TherapeuticsMD director Tommy Thompson acquires $325 in stock By Investing.com - Investing.com Canada
TherapeuticsMD CEO Marlan Walker acquires $489 in common stock - Investing.com
TherapeuticsMD CEO Marlan Walker buys $489 in common stock By Investing.com - Investing.com South Africa
TherapeuticsMD CEO Marlan Walker buys $489 in common stock - Investing.com
INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire
DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire
Mayne Pharma Faces Legal Challenge from TherapeuticsMD - TipRanks
TherapeuticsMD CEO Marlan Walker buys $1,994 in stock - Investing.com Australia
TherapeuticsMD CEO Marlan Walker buys $1,994 in stock By Investing.com - Investing.com India
TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch
TherapeuticsmdFiles Lawsuit Against Mayne Pharma For Breach Of Contract - marketscreener.com
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Therapeuticsmd Inc (TXMD) 財務データ
収益
当期純利益
現金流量
EPS
0.57%
大文字化:
|
ボリューム (24 時間):